These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27806714)

  • 1. The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.
    Gehre F; Otu J; Kendall L; Forson A; Kwara A; Kudzawu S; Kehinde AO; Adebiyi O; Salako K; Baldeh I; Jallow A; Jallow M; Dagnra A; Dissé K; Kadanga EA; Idigbe EO; Onubogu C; Onyejepu N; Gaye-Diallo A; Ba-Diallo A; Rabna P; Mane M; Sanogo M; Diarra B; Dezemon Z; Sanou A; Senghore M; Kwambana-Adams BA; Demba E; Faal-Jawara T; Kumar S; Tientcheu LD; Jallow A; Ceesay S; Adetifa I; Jaye A; Pallen MJ; D'Alessandro U; Kampmann B; Adegbola RA; Mboup S; Corrah T; de Jong BC; Antonio M
    BMC Med; 2016 Nov; 14(1):160. PubMed ID: 27806714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
    Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
    Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
    PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
    Schaaf HS; Moll AP; Dheda K
    Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
    PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
    Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
    PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
    Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
    J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.
    Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D;
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
    Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
    Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
    Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA
    Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.